Dupixent (dupilumab) approved as the first-ever biologic medicine in Japan for patients with Chronic Obstructive Pulmonary Disease (COPD)
Omega 3 oil 18 EPA/12 DHA is highly demanded worldwide for its multiple benefits for human and animal health
Will add UNLOXCYT (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for metastatic or locally advanced cutaneous squamous cell carcinoma (cSCC) to Sun Pharma's global onco-derm franchise
Innovative chronic pain treatment receives IP protection in India's $55 billion pharmaceutical market
The safety profile of Opdualag observed in this analysis was consistent with the known profiles of nivolumab and relatlimab
EBITDA rose to Rs. 14.8 crore, marking a 16.5% y-o-y increase, while net profit surged to Rs. 6.4 crore
AA Signature provides an innovative approach to treatment planning that focuses on patient outcomes
Novel illumination system with key components molded in Radel® PPSU for durability and repeated sterilization
Earlier, Cupid Limited had been eligible to supply 75% of the contract for female condoms in previous tenders
Based on ECHO Phase III trial results which showed more than 16 months of progression-free survival improvement vs. chemoimmunotherapy alone
Subscribe To Our Newsletter & Stay Updated
